Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Status and future directions of clinical trials in Alzheimer's disease.
TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Status and future directions of clinical trials in Alzheimer's disease.
Status and future directions of clinical trials in Alzheimer's disease. Int Rev Neurobiol. 2020; 154:3-50.
View in:
PubMed
subject areas
Alzheimer Disease
Amyloid beta-Peptides
Anti-Inflammatory Agents
Apolipoproteins E
Cell- and Tissue-Based Therapy
Clinical Trials as Topic
Genetic Therapy
Humans
Immunologic Factors
Neuroprotective Agents
Neurotransmitter Agents
tau Proteins
authors with profiles
George Perry